Clinical trials: Airway Reactivity

Allergic Asthma

Pemirolast in Allergen Challenge (PEMAG)

• Terminated
• Age: 18 to 65 years
• Phase 2

The purpose of this study is to establish the influence of the non-steroidal candidate-drug pemirolast on allergen-induced airway obstruction and inflammation in allergic subjects with asthma.

Trial name

PEMAG (NCT03119714)

Testing

Pemirolast

Where

Sweden

Volunteers

1 people

Sponsor

Karolinska University Hospital